Protagonist Therapeutics Inc (PTGX)
Operating Expenses
$223.24M
TTM · Period ending: · USD
PTGX Operating Expenses
Latest reported$223.24Mperiod ending
Latest reported$223.24Mperiod ending
PTGX TTM Operating Expenses ($14.79M → $223.24M)
TTM operating expenses
High-resolution chart · PNG
PTGX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 223,243,000 | |
| 216,121,000 | |
| 204,143,000 | |
| 190,209,000 | |
| 185,204,000 | |
| 180,577,000 | |
| 181,590,000 | |
| 174,683,000 | |
| 166,881,000 | |
| 166,275,000 | |
| 153,652,000 | |
| 153,217,000 | |
| 147,194,000 | |
| 146,299,000 | |
| 156,278,000 | |
| 165,476,000 | |
| 177,385,000 | |
| 169,073,000 | |
| 153,283,000 | |
| 132,049,000 | |
| 108,723,000 | |
| 100,010,000 | |
| 93,144,000 | |
| 88,682,000 | |
| 89,104,000 | |
| 87,888,000 | |
| 80,752,000 | |
| 78,499,000 | |
| 72,697,000 | |
| 70,392,000 | |
| 73,194,000 | |
| 70,224,000 | |
| 68,479,000 | |
| 62,697,000 | |
| 57,960,000 | |
| 54,562,000 | |
| 47,939,000 | |
| 39,899,000 | |
| 32,666,000 | |
| 26,270,000 | |
| 23,153,000 | |
| 19,145,000 | |
| 14,794,000 |